US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GSK plc ADRhedged

66.97

-0.0976-0.15%

Post-market: 66.970.00000.00%16:10 EDT

Volume:215

Turnover:14.38K

Market Cap:669.77K

PE:- -

High:66.97

Open:66.84

Low:66.84

Close:67.07

52wk High:85.03

52wk Low:55.75

Shares:10.00K

Float Shares:10.00K

Volume Ratio:1.19

T/O Rate:2.15%

Dividend:2.08

Dividend Rate:3.10%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

GSK Stops Camlipixant Program in Refractory Chronic Cough After Phase 3 Data

MT Newswires Live

GSK Halts Camlipixant Development in Chronic Cough After Mixed Phase III Results

GSK Advances New Infant Pneumococcal Vaccine Into Early-Stage Testing

GSK executives boost holdings via dividend-funded ADS purchases

GSK’s New Phase 3 Ovarian Cancer Trial Puts Mo-Rez in the First-Line Spotlight

Is AnaptysBio (ANAB) Undervalued Following Its Jemperli Royalty Appeal And GSK Trial?

Simply Wall St.

GSK Completes $10.6 Billion Acquisition of Nuvalent

MT Newswires Live

iX Biopharma Warrants See Strong Insider Take-Up, Funding U.S. Expansion

GSK Executives Acquire Shares Under Routine Reward Plan

UBS Remains a Hold on GlaxoSmithKline (GSK)

GSK’s Jemperli Trial Points to Chemo‑Free Future for Subset of Rectal Cancer Patients

Insilico Medicine Surges Over 7% in Morning Trading on New AI Drug Discovery Partnership with CMS

Guggenheim Remains a Hold on GlaxoSmithKline (GSK)

GSK says Hansoh Pharma announces positive phase 3 results for Ris-Rez in China

Revenue Revision at Frontier Biotech Highlights Channel Pressures as Operating Losses Widen

GSK US President Acquires Notional ADS Under Executive Savings Plan

GSK Adds Philips CEO Roy Jakobs to Board as Independent Director

SBP GROUP Shares Surge Over 5% in Early Trading on Deepened Strategic Alliance with GLAXOSMITHKLINE

Alector Ends GSK Collaboration, Retires Hercules Capital Debt

GSK’s New RSV/hMPV Vaccine Trial Adds Momentum to Its Respiratory Portfolio

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/GSKH/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":66.9705,"timestamp":1789156800000,"preClose":67.0681,"halted":0,"volume":215,"hourTrading":{"tag":"盘后","latestPrice":66.9705,"preClose":66.9705,"latestTime":"16:10 EDT","volume":6,"amount":401.823,"timestamp":1789157404582,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0014552372886662945,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"Post-Mkt","change":-0.0976,"latestTime":"09-11 17:32:06 EDT","open":66.84,"high":66.9705,"low":66.84,"amount":14383,"amplitude":0.001946,"askPrice":100.44,"askSize":200,"bidPrice":33.48,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789171200000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":67.0681,"nav":67.507158,"aum":675139.087158,"dividendRate":0.031045,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":66.9705,"preClose":66.9705,"latestTime":"16:10 EDT","volume":6,"amount":401.823,"timestamp":1789157404582,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.194446,"impliedVol":0.3507,"impliedVolPercentile":0.9735},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.194446,"shares":10001,"dividePrice":2.0791,"high":66.9705,"amplitude":0.001946,"preClose":67.0681,"low":66.84,"week52Low":55.7526,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":66.9705,"eps":0,"divideRate":0.031045,"volume":215,"delay":0,"ttmEps":0,"open":66.84,"prevYearClose":68.2031,"prevWeekClose":69.5112,"prevMonthClose":69.8569,"prevQuarterClose":73.8574,"fiveDayClose":70.7456,"twentyDayClose":69.8223,"sixtyDayClose":72.7498},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2652402537","title":"GSK Stops Camlipixant Program in Refractory Chronic Cough After Phase 3 Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2652402537","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652402537?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:22","pubTimestamp":1784283728,"startTime":"0","endTime":"0","summary":"GSK  will discontinue development of camlipixant for refractory chronic cough after the drug produced mixed results in the phase 3 CALM-1 and CALM-2 trials, the company said Friday.In the phase 3 program, camlipixant 50 mg twice daily significantly reduced 24-hour cough frequency versus placebo in CALM-1 but failed to reach statistical significance in CALM-2, while the 25 mg dose failed to meet the primary endpoint in both trials.GSK said limited efficacy prompted its decision to discontinue camlipixant's development in refractory chronic cough, while the phase 2b BALANCE trial in irritable bowel syndrome will continue.GSK shares were down over 3% in premarket activity Friday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","GSKH","BK4588","GSK","LU1829250122.USD","BK4585","GSK.UK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652406846","title":"GSK Halts Camlipixant Development in Chronic Cough After Mixed Phase III Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2652406846","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652406846?lang=en_us&edition=fundamental","pubTime":"2026-07-17 16:32","pubTimestamp":1784277143,"startTime":"0","endTime":"0","summary":"The latest update is out from GlaxoSmithKline ( ($GB:GSK) ). GSK has reported mixed phase III results for its P2X3 receptor antagonist camlipixant ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-halts-camlipixant-development-in-chronic-cough-after-mixed-phase-iii-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-halts-camlipixant-development-in-chronic-cough-after-mixed-phase-iii-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSK.UK","BK4007","BK4588","BK4585","III","GSKH","GSK","BK4532","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652042578","title":"GSK Advances New Infant Pneumococcal Vaccine Into Early-Stage Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2652042578","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652042578?lang=en_us&edition=fundamental","pubTime":"2026-07-17 00:31","pubTimestamp":1784219518,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is launching a Phase 1 trial to test an infant pneumoco...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-advances-new-infant-pneumococcal-vaccine-into-early-stage-testing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-advances-new-infant-pneumococcal-vaccine-into-early-stage-testing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BK4588","BBC","BK4007","GSK.UK","LU1829250122.USD","GSKH","BK4585","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651428983","title":"GSK executives boost holdings via dividend-funded ADS purchases","url":"https://stock-news.laohu8.com/highlight/detail?id=2651428983","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651428983?lang=en_us&edition=fundamental","pubTime":"2026-07-16 22:32","pubTimestamp":1784212352,"startTime":"0","endTime":"0","summary":"The latest update is out from GlaxoSmithKline ( ($GB:GSK) ). GSK has disclosed a series of transactions in which several senior executives and non-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executives-boost-holdings-via-dividend-funded-ads-purchases?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executives-boost-holdings-via-dividend-funded-ads-purchases?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","BK4532","BK4007","VIG","BK4585","GSKH","GSK.UK","BK4588","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651467645","title":"GSK’s New Phase 3 Ovarian Cancer Trial Puts Mo-Rez in the First-Line Spotlight","url":"https://stock-news.laohu8.com/highlight/detail?id=2651467645","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651467645?lang=en_us&edition=fundamental","pubTime":"2026-07-16 00:31","pubTimestamp":1784133105,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is launching a phase 3 trial called BEHOLD-Ovaria...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-phase-3-ovarian-cancer-trial-puts-mo-rez-in-the-first-line-spotlight?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-phase-3-ovarian-cancer-trial-puts-mo-rez-in-the-first-line-spotlight?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","GSK.UK","GSKH","LU1829250122.USD","BK4585","BK4588","BK4007","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651846405","title":"Is AnaptysBio (ANAB) Undervalued Following Its Jemperli Royalty Appeal And GSK Trial?","url":"https://stock-news.laohu8.com/highlight/detail?id=2651846405","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651846405?lang=en_us&edition=fundamental","pubTime":"2026-07-15 22:36","pubTimestamp":1784126191,"startTime":"0","endTime":"0","summary":"Laughing Water Capital’s recent decision to add AnaptysBio (ANAB) has drawn attention because it hinges on two factors: royalty income from the cancer drug Jemperli and an imminent commercial trial with partner GSK.\nSee our latest analysis for AnaptysBio.\nDespite the recent legal spotlight, AnaptysBio’s share price has been volatile, with a 1-day share price return down 10.46% and a 7-day share price return down 7.15%. However, a year-to-date share price return of 39.07% sits alongside a very...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anab/anaptysbio/news/is-anaptysbio-anab-undervalued-following-its-jemperli-royalt","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anab/anaptysbio/news/is-anaptysbio-anab-undervalued-following-its-jemperli-royalt","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ANAB","LU1829250122.USD","GSK.UK","BK4532","BK4139","BK4007","BK4585","GSKH","GSK","BK4588","FFTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651690154","title":"GSK Completes $10.6 Billion Acquisition of Nuvalent","url":"https://stock-news.laohu8.com/highlight/detail?id=2651690154","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651690154?lang=en_us&edition=fundamental","pubTime":"2026-07-15 22:16","pubTimestamp":1784124997,"startTime":"0","endTime":"0","summary":"GSK  said Wednesday it has completed the acquisition of Nuvalent , a Boston-based clinical-stage biopharmaceutical company, in a transaction with an aggregate equity value of about $10.6 billion.The transaction, which represents a net investment of about $9.4 billion after accounting for acquired cash, was finalized through a tender offer for all outstanding Nuvalent shares.The deal adds three lung cancer assets to GSK's oncology portfolio, according to a statement.Price: 51.55, Change: +0.30, Percent Change: +0.58","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4532","GSK.UK","LU1829250122.USD","BK4588","GSK","BK4139","BK4539","GSKH","NUVL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651468729","title":"iX Biopharma Warrants See Strong Insider Take-Up, Funding U.S. Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2651468729","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651468729?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:08","pubTimestamp":1784117284,"startTime":"0","endTime":"0","summary":"The latest update is out from iX Biopharma Ltd. ( ($SG:42C) ). Singapore-based iX Biopharma Ltd. operates in the biopharmaceutical industry, focusi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ix-biopharma-warrants-see-strong-insider-take-up-funding-u-s-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ix-biopharma-warrants-see-strong-insider-take-up-funding-u-s-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4209","GSKH","PPH","SURI","SG","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651110571","title":"GSK Executives Acquire Shares Under Routine Reward Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2651110571","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651110571?lang=en_us&edition=fundamental","pubTime":"2026-07-13 22:32","pubTimestamp":1783953145,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK has disclosed multiple small share acquisitions by senior executives under the company’s ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executives-acquire-shares-under-routine-reward-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executives-acquire-shares-under-routine-reward-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","GSK.UK","BK4585","GSK","BK4007","BK4588","GSKH","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651511137","title":"UBS Remains a Hold on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651511137","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651511137?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:16","pubTimestamp":1783944989,"startTime":"0","endTime":"0","summary":"UBS analyst Matthew Weston maintained a Hold rating on GlaxoSmithKline today and set a price target of £19.40. According to TipRanks, Weston is a 4...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ubs-remains-a-hold-on-glaxosmithkline-gsk-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ubs-remains-a-hold-on-glaxosmithkline-gsk-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","BK4007","GSK","BK4588","GSKH","GSK.UK","BK4585","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651954591","title":"GSK’s Jemperli Trial Points to Chemo‑Free Future for Subset of Rectal Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2651954591","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651954591?lang=en_us&edition=fundamental","pubTime":"2026-07-13 14:09","pubTimestamp":1783922982,"startTime":"0","endTime":"0","summary":"The latest update is out from GlaxoSmithKline ( ($GB:GSK) ). GSK has reported positive interim phase II AZUR-1 data for its PD‑1 inhibitor Jemperli...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-jemperli-trial-points-to-chemofree-future-for-subset-of-rectal-cancer-patients?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-jemperli-trial-points-to-chemofree-future-for-subset-of-rectal-cancer-patients?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4585","PCOM","BK4007","GSKH","LU1829250122.USD","GSK","BK4122","BK4588","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156997423","title":"Insilico Medicine Surges Over 7% in Morning Trading on New AI Drug Discovery Partnership with CMS","url":"https://stock-news.laohu8.com/highlight/detail?id=1156997423","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156997423?lang=en_us&edition=fundamental","pubTime":"2026-07-13 10:10","pubTimestamp":1783908642,"startTime":"0","endTime":"0","summary":"Insilico Medicine (03696) shares rose more than 7% in early trading. At the time of writing, the stock is up 6.21% to HK$45.48, with a turnover of HK$332 million. On July 13th, according to a post on...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015945.SGD","WRND","BBP","IE00BMCWC346.EUR","PBE","IE00BGHQDM52.EUR","00867","LFSC","LU2488822045.USD","AGIX","IBB","BK1191","IE00BVYPNP33.GBP","AIPO","SG9999015986.USD","GSKH","BK4585","IE00BYV24P56.USD","SBIO","SG9999004220.SGD","SG9999015978.USD","SG9999015952.SGD","VTHR","ARTY","BK1593","IE00BVYPNQ40.USD","QTOC","BK4588","CHAT","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650139214","title":"Guggenheim Remains a Hold on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650139214","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650139214?lang=en_us&edition=fundamental","pubTime":"2026-07-10 23:45","pubTimestamp":1783698318,"startTime":"0","endTime":"0","summary":"Guggenheim analyst maintained a Hold rating on GlaxoSmithKline yesterday. The company’s shares closed today at p1,959.50. In addition to Guggenheim...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-remains-a-hold-on-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-remains-a-hold-on-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4532","GSK.UK","BK4007","GSKH","LU1829250122.USD","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650182181","title":"GSK says Hansoh Pharma announces positive phase 3 results for Ris-Rez in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2650182181","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650182181?lang=en_us&edition=fundamental","pubTime":"2026-07-10 19:10","pubTimestamp":1783681857,"startTime":"0","endTime":"0","summary":"GSK (GSK) plc licensor Hansoh Pharmaceutical Group announced that ARTEMIS-008, its pivotal phase III trial evaluating risvutatug rezetecan, or Ris-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-says-hansoh-pharma-announces-positive-phase-3-results-for-ris-rez-in-china-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-says-hansoh-pharma-announces-positive-phase-3-results-for-ris-rez-in-china-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","BK4532","GSKH","BK4007","LU1829250122.USD","GSK","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121894437","title":"Revenue Revision at Frontier Biotech Highlights Channel Pressures as Operating Losses Widen","url":"https://stock-news.laohu8.com/highlight/detail?id=1121894437","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121894437?lang=en_us&edition=fundamental","pubTime":"2026-07-10 14:21","pubTimestamp":1783664489,"startTime":"0","endTime":"0","summary":"Frontier Biotech has responded to the Shanghai Stock Exchange's 2025 annual report inquiry letter, providing clarifications on issues including revenue recognition adjustments, distributor inventory,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","GSK.UK","GSKH","SPHQ","GSK","LU1829250122.USD","BK4588","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650978583","title":"GSK US President Acquires Notional ADS Under Executive Savings Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2650978583","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650978583?lang=en_us&edition=fundamental","pubTime":"2026-07-09 22:32","pubTimestamp":1783607547,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK disclosed that Maya Martinez-Davis, President of US operations and a person discharging m...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-us-president-acquires-notional-ads-under-executive-savings-plan-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-us-president-acquires-notional-ads-under-executive-savings-plan-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSKH","BK4532","BK4588","GSK.UK","BK4585","GSK","LU1829250122.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650940152","title":"GSK Adds Philips CEO Roy Jakobs to Board as Independent Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2650940152","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650940152?lang=en_us&edition=fundamental","pubTime":"2026-07-09 17:02","pubTimestamp":1783587750,"startTime":"0","endTime":"0","summary":"The latest announcement is out from GlaxoSmithKline ( ($GB:GSK) ). GSK has appointed Roy Jakobs, the current chief executive of health technology g...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-adds-philips-ceo-roy-jakobs-to-board-as-independent-director?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-adds-philips-ceo-roy-jakobs-to-board-as-independent-director?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4532","BK4585","GSK","GSKH","LU1829250122.USD","BK4588","EKG","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115056703","title":"SBP GROUP Shares Surge Over 5% in Early Trading on Deepened Strategic Alliance with GLAXOSMITHKLINE","url":"https://stock-news.laohu8.com/highlight/detail?id=1115056703","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115056703?lang=en_us&edition=fundamental","pubTime":"2026-07-09 10:21","pubTimestamp":1783563660,"startTime":"0","endTime":"0","summary":"Shares of SBP GROUP (01177) climbed more than 5% during the morning session. At the time of writing, the stock was up 5.39% to HK$5.08, with a turnover of HK$239 million. Expanding a Strategic...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","BK1515","LU1829250122.USD","BK1589","HK0000165453.HKD","BK4532","BK4007","GSK.UK","IE00BZ08YR35.GBP","BK1191","01177","BK4588","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","GSKH","GSK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650291696","title":"Alector Ends GSK Collaboration, Retires Hercules Capital Debt","url":"https://stock-news.laohu8.com/highlight/detail?id=2650291696","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650291696?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:32","pubTimestamp":1783542774,"startTime":"0","endTime":"0","summary":"Alector ( ($ALEC) ) has provided an announcement. On October 21, 2025, Alector reported that its Phase 3 INFRONT-3 trial of latozinemab in frontote...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alector-ends-gsk-collaboration-retires-hercules-capital-debt?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alector-ends-gsk-collaboration-retires-hercules-capital-debt?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","PBDC","PEX","BK4585","LU1829250122.USD","HTGC","BIZD","BK4532","BK4007","GSK","GSK.UK","GSKH","FXED","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650861990","title":"GSK’s New RSV/hMPV Vaccine Trial Adds Momentum to Its Respiratory Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2650861990","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650861990?lang=en_us&edition=fundamental","pubTime":"2026-07-09 00:32","pubTimestamp":1783528353,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GSK steps up its respiratory vaccine push with a new study, NCT07628049...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-rsv-hmpv-vaccine-trial-adds-momentum-to-its-respiratory-portfolio?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-rsv-hmpv-vaccine-trial-adds-momentum-to-its-respiratory-portfolio?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSKH","GSK.UK","BK4585","BK4532","GSK","LU1829250122.USD","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}